Zobrazeno 1 - 10
of 55
pro vyhledávání: '"BENJAMIN P. SOULE"'
Autor:
Paul Emery, Yoshiya Tanaka, Vivian P. Bykerk, Thomas W. J. Huizinga, Gustavo Citera, Clifton O. Bingham, Subhashis Banerjee, Benjamin P. Soule, Marleen Nys, Sean E. Connolly, Karissa L. Lozenski, Joe Zhuo, Robert Wong, Kuan-Hsiang Gary Huang, Roy Fleischmann
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 3, Pp 707-727 (2023)
Abstract Introduction One target of rheumatoid arthritis (RA) treatment is to achieve early sustained remission; over the long term, patients in sustained remission have less structural joint damage and physical disability. We evaluated Simplified Di
Externí odkaz:
https://doaj.org/article/031a80a1de6645ab8805525b4951051a
Autor:
Julie Mitchell, John B Buse, Mark Cziraky, Helene Nordahl Christensen, Brian J Harty, Benjamin P Soule, Emily Zacherle, Vincent J Willey
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 11, Iss 3 (2023)
Introduction Once-weekly subcutaneous semaglutide, a glucagon-like peptide-1 analog, is approved in the USA as an adjunct to diet and exercise for adults with inadequately controlled type 2 diabetes (T2D) to improve glycemic control and reduce the ri
Externí odkaz:
https://doaj.org/article/77d455d5e5a749fe90779bba7ee518f9
Autor:
John B Buse, Helene Nordahl Christensen, Brian J Harty, Julie Mitchell, Benjamin P Soule, Emily Zacherle, Mark Cziraky, Vincent J Willey
Publikováno v:
BMJ Open Diabetes Research & Care. 11:e003206
IntroductionOnce-weekly subcutaneous semaglutide, a glucagon-like peptide-1 analog, is approved in the USA as an adjunct to diet and exercise for adults with inadequately controlled type 2 diabetes (T2D) to improve glycemic control and reduce the ris
Autor:
VINCENT WILLEY, JOHN B. BUSE, BRIAN HARTY, JULIE L. MITCHELL, BENJAMIN P. SOULE, HELENE N. CHRISTENSEN, MARK J. CZIRAKY, SIMON SKIBSTED
Publikováno v:
Diabetes. 71
SEPRA (NCT03596450) is a 2-yr, multicenter, open-label, randomized pragmatic clinical trial comparing the long-term effects of once-weekly subcutaneous semaglutide vs. standard of care (both added to ≤2 oral antidiabetic medications) in US health-i
Autor:
Anthony D. Saleh, Jason E. Savage, Liu Cao, Benjamin P. Soule, David Ly, William DeGraff, Curtis C. Harris, James B. Mitchell, Nicole L. Simone
Publikováno v:
PLoS ONE, Vol 7, Iss 4 (2012)
Externí odkaz:
https://doaj.org/article/361a1237f7da449ab55c98bb827fc767
Autor:
Anthony D Saleh, Jason E Savage, Liu Cao, Benjamin P Soule, David Ly, William DeGraff, Curtis C Harris, James B Mitchell, Nicole L Simone
Publikováno v:
PLoS ONE, Vol 6, Iss 10, p e24429 (2011)
Genotoxic stressors, such as radiation, induce cellular damage that activates pre-programmed repair pathways, some of which involve microRNAs (miRNA) that alter gene expression. The let-7 family of miRNA regulates multiple cellular processes includin
Externí odkaz:
https://doaj.org/article/898530fedc164e3c9fe5d88c1f209525
Autor:
Nicole L Simone, Benjamin P Soule, David Ly, Anthony D Saleh, Jason E Savage, William Degraff, John Cook, Curtis C Harris, David Gius, James B Mitchell
Publikováno v:
PLoS ONE, Vol 4, Iss 7, p e6377 (2009)
BACKGROUND:MicroRNAs (miRNAs) are small, highly conserved, non-coding RNA that alter protein expression and regulate multiple intracellular processes, including those involved in the response to cellular stress. Alterations in miRNA expression may oc
Externí odkaz:
https://doaj.org/article/9c1bacd4cad947c488e5e02b40d29a7f
Autor:
Nicholas G. Zaorsky, Benjamin P. Soule, Brittany A. Simone, Joshua D. Palmer, Nicole L. Simone, Lianjin Jin
Publikováno v:
Ageing Research Reviews. 17:16-24
As the link between metabolism and major disease processes becomes more well-defined, the identification of key molecular targets is leading to new therapeutic strategies. As a result, small non-coding RNA molecules that regulate gene expression via
Autor:
Nitin Ohri, J.B. Mitchell, David Ly, S. L. Smith, Kevin Camphausen, Nicole L. Simone, Marc E. Lippman, K. Matsuda, Stephen M. Hewitt, Tu Dan, Benjamin P. Soule, Uma Shankavaram
Publikováno v:
Breast Cancer Res Treat
CD44 is a transmembrane glycoprotein involved in numerous cellular functions, including cell adhesion and extracellular matrix interactions. It is known to be functionally diverse, with alternative splice variants increasingly implicated as a marker
Autor:
Mark S. Litwin, Anurag K. Singh, Benjamin P. Soule, Nicole L. Simone, Janet E. Cowan, Peter R. Carroll
Publikováno v:
Journal of Urology. 180:2447-2452
Most men diagnosed with prostate cancer will die of other causes and pretreatment patient characteristics may identify those who are likely to die of other causes. Accurate stratification of patients by risk of other cause mortality may reduce needle